Mandate

Vinge advises Geveko in connection with its new share issue

February 25, 2010

AB Geveko (publ) has resolved to carry out a new share issue with preferential rights for the shareholders. Through the new issue, which is fully committed and underwritten, the company will raise approximately SEK 160 million excluding transaction costs. The new issue is subject to approval by the extraordinary shareholders’ meeting on 31 March 2010.

AB Geveko is listed on NASDAQ OMX Stockholm.

Vinge’s team consisted primarily of responsible partner Göran Nyström and the associates Anna Björk Larson and Emil Hedberg.

Related

Vinge advises SAGA Diagnostics AB on convertible note issue

SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue of approximately SEK 144 million. Vinge advised SAGA Diagnostics in connection with the transaction.
September 28, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences group that develops and commercializes highly innovative bioprocess technologies and systems that enable efficiency in the biopharmaceutical manufacturing process, in connection with its acquisition of Metenova Holding AB with subsidiaries (“Metenova”).
September 27, 2023

Vinge has advised private equity firm Stirling Square Capital Partners

Vinge has advised private equity firm Stirling Square Capital Partners in connection with its acquisition of a majority stake in Infobric, a leading provider of software solutions for the construction industry, from Summa Equity.
September 22, 2023